NCT03554200 - EMPA Acute Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

October 29, 2020

Study Completion Date

October 29, 2020

Conditions

Diabetes Mellitus, Type 2Acute Heart Failure

Interventions

DRUG

Empagliflozin

Standard of Care + Empagliflozin: 10 mg (tablets) once daily

DRUG

Placebo

Standard of Care + Placebo: Matching Placebo (tablets) once daily

Trial Locations (1)

Department of Internal Medicine I RWTH Aachen University Hospital, Aachen